baber/WOPTO huggingface dataset:
Patent CY-1117207-T1 (CY)
Title: Ιξωδοελαστικες γελες ως νεα υλικα πληρωσης
Inventor: D'ESTE MATTEO
IPC: C08L5/08
Filed: 2016-02-18
Abstract: Βιοϋλικά τα οποία είναι δυνατόν να λαμβάνονται δια ανάμιξης του αυτοσταυροσυνδεδεμένου παραγώγου υαλουρονικού οξέος (ACP) με το παράγωγο (HBC) το οποίο σταυροδένεται με 1,4-βουτανοδιολοδιγλυκιδυλαιθέρα (BDDE) σε κατά βάρος αναλογία μεταξύ 10:90 και 90:10 ως νέα υλικά πλήρωσης.
Patent CY-1118640-T1 (CY)
Title: Μορια αντισωματος που εχουν ειδικοτητα προσδεσης για την ανθρωπινη il-13
Inventor: GOZZARD NEIL
IPC: C12N15/13
Filed: 2017-02-16
Abstract: Μόρια αντισώματος που έχουν ειδικότητα για αντιγονικούς καθοριστικούς παράγοντες της ανθρώπινης IL-13, θεραπευτικές χρήσεις των μορίων αντισώματος κα μέθοδοι παραγωγής των εν λόγω μορίων αντισώματος.
Patent CY-1120608-T1 (CY)
Title: Φαρμακευτικως δραστικες ενωσεις
Inventor: BLAGG JULIAN
IPC: C07D471/04
Filed: 2018-03-06
Abstract: Η παρούσα εφεύρεση αφορά σε ενώσεις του τύπου I: όπου R1 και R2 είναι όπως ορίζονται στο παρόν, ή φαρμακευτικώς αποδεκτό άλας ή διαλύτωμα αυτών. Οι ενώσεις του τύπου I είναι αναστολείς κινάσης aurora ή/και FLT3. Η παρούσα εφεύρεση επίσης αφορά σε μεθόδους για την παρασκευή αυτών των ενώσεων, σε φαρμακευτικές συνθέσεις που περιλαμβάνουν αυτές και στη χρήση αυτών στη θεραπεία πολλαπλασιαστικών διαταραχών, όπως καρκίνου, καθώς επίσης άλλων ασθενειών ή καταστάσεων όπου ενοχοποιείται δραστικότητα κινάσης aurora ή/και FLT3.
Patent CY-1120383-T1 (CY)
Inventor: BUELOW RONALD
IPC: C12N15/13
Filed: 2018-03-27
Abstract: The invention relates to transgenic animals lacking endogenous Ig and capable of producing transgenic antibodies, as well as methods of making the same. The invention further relates to methods for producing transgenic antibodies in such animals, and transgenic antibodies so produced.
Patent CY-1122454-T1 (CY)
Title: Στερεες δοσολογικες μορφες palbociclib
Inventor: IBRAHIM FADY MAKRAM LOUIZ
IPC: A61K9/28
Filed: 2020-01-03
Abstract: Η παρούσα εφεύρεση αναφέρεται σε στερεές δοσολογικές μορφές palbociclib που περιλαμβάνουν ένα υδατοδιαλυτό οξύ. Οι περιγραφόμενες στο παρόν δοσολογικές μορφές έχουν επιθυμητά φαρμακοκινητικά χαρακτηριστικά.
Patent CY-1126107-T1 (CY)
Title: Διασπειρομενες συνθεσεις
Inventor: GUPTA MANISH KUMAR
IPC: A61K9/00
Filed: 2023-07-07
Abstract: Η παρούσα εφεύρεση αφορά διασπειρόμενες συνθέσεις που περιλαμβάνουν φουμαρική βεδακιλίνη ως δραστικό συστατικό. Τέτοιες συνθέσεις είναι χρήσιμες για τη θεραπεία της φυματίωσης και οι εγγενείς ιδιότητες διασποράς τους προσφέρονται ως χρήσιμες ιδίως μεταξύ του παιδιατρικού ή του γηριατρικού πληθυσμού.
Patent GR-990300029-T1 (GR)
Title: Valve apparatus for use with an iv set
Inventor: JEMMOTT GILBERT F
IPC: A61M5/168
Filed: 1997-07-28
Abstract: A valve apparatus employs a spherical sealing element disposed in resiliently deformable tubing. The dimensions of the sealing element are selected such that the valve opens when subjected to a cracking pressure that is greater than the head pressure developed in an IV set and less than the pressure generated by a peristaltic pump. The valve additionally has an actuator element associated therewith that may be applied to the tubing about the sealing element to cause free flow without the need for continuous manipulation.
Patent HR-P20110190-T1 (HR)
Inventor: PETERS DAN
IPC: A61P25/28
Filed: 2011-03-15
Abstract: Kemijski spoj naznačen time, što je egzo-7-(8-H-8-aza-biciklo[3.2.1]okt-3-iloksi)-kromen-2-ona; ili njegova farmaceutski prihvatljiva sol. Patent sadrži još 7 patentnih zahtjeva.
Patent SI-1173433-T1 (SI)
Title: Cyanopyrroles as progesterone receptor agonists
Inventor: COLLINS MARK A
IPC: A61K31/00
Filed: 2000-05-01
Abstract: This invention provides a progesterone receptor antagonist of formula 1 having the structure wherein, T is O, S, or absent; R1, and R2 are each, independently, hydrogen, alkyl, substituted alkyl; or R1 and R2 are taken together form a ring and together contain -CH2(CH2)nCH2-, -CH2CH2CMe2CH2CH2-, -O(CH2)pCH2-, -O(CH2)qO-, -CH2CH2OCH2CH2-, or -CH2CH2NR7CH2CH2-; n=1-5; p=1-4; q=1-4; R3 is hydrogen, OH, NH2, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, or CORA; RA is hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aminoalkyl, or substituted aminoalkyl; R4 is hydrogen, halogen, CN, NH2, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aminoalkyl, or substituted aminoalkyl; R5 is hydrogen, alkyl, or substituted alkyl; R6 is hydrogen, alkyl, substituted alkyl, or CORB; RB is hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aminoalkyl, or substituted aminoalkyl; R7 is hydrogen or alkyl; or a pharmaceutically acceptable salt thereof.
Patent SI-1992622-T1 (SI)
Title: 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
Inventor: MIYAZAKI KAZUKI
IPC: A61K31/517
Filed: 2007-02-20
Abstract: A compound represented by the following formula, salt thereof or hydrate thereof, can effectively relieve itch caused by atopic disesae or the like: wherein R represents hydroxyl, C1-6 alkoxy optionally substituted with C1-6 alkoxy, or amino optionally substituted with C1-6 alkyl.
Patent SI-3095484-T1 (SI)
Title: Calcitonin mimetics for treating diseases and disorders
Inventor: MEHTA NOZER M
IPC: C07K5/00
Filed: 2012-11-02
Abstract: A pharmaceutical co-formulation comprising a calcitonin mimetic and an insulin sensitiser, and its use in the treatment type I diabetes, type II diabetes or a metabolic syndrome, or for reducing an undesirably high fasting serum glucose level, or for reducing an undesirably high peak serum glucose level, or for reducing an undesirably high peak serum insulin level, or for reducing an undesirably large response to a glucose tolerance test.
Patent SI-3157910-T1 (SI)
Title: Process for the selective oxidation of 5-hydroxymethylfurfural
Inventor: MIHOVILOVIC MARKO
IPC: C07D307/00
Filed: 2015-06-17
Abstract: Process for the selective production of oxidized furan derivatives starting from 5-hydroxymethyl-2-furfural in the presence of a solvent, an oxidation agent, a catalyst, and optionally a base, which process is characterized in that the oxidation process is carried out continuously in flow, and there are provided means for varying reaction parameters.
Patent DE-3685938-T2 (DE)
Inventor: HIGBIE FRANCIS A
IPC: C07C43/11
Filed: 1986-07-11
Granted: 1992-12-24
Abstract: Radiation curable compositions containing outstanding reactive diluents have been developed. The diluents are lower alkyl ether acrylates and methacrylates of particular alkoxylated and non-alkoxylated polyols. Examples are mono-methoxy trimethylolpropane diacrylate, mono-methoxy neopentyl glycol monoacrylate and mono-methoxy, ethoxylated neopentyl glycol monoacrylate having an average of about two moles of ethylene oxide.
Patent DE-3751635-T2 (DE)
Inventor: COLETTE WAYNE N
IPC: B29C49/64
Filed: 1987-05-25
Granted: 1996-05-02
Abstract: A method of blow moulding a returnable/refillable container in the form of a polyester biaxially oriented bottle having a physical and structural relationship providing for the maintenance of aesthetic and functional viability over a minimum of five trips wherein each trip comprises (1) an empty state caustic wash followed by (2) contaminant inspection and product filling/capping, (3) warehouse storage, (4) distribution to wholesale and retail locations, and (5) purchase, use and empty storage by the consumer followed by return to a bottler. The container is obtained utilizing a specific preform configuration and reheat blow process wherein the sidewall of the resultant container has a percent crystallinity of 24-30 at a total preform draw ratio of 7-9/1. The container is formed utilizing recently developed process techniques to optimize strain induced sidewall crystallization.
Patent DE-3751908-T2 (DE)
Inventor: SCHOEMAKER HUBERT J P
IPC: A61K38/00
Filed: 1987-07-07
Granted: 1997-02-06
Abstract: Chimeric rodent/human antibodies specific for cancer cell antigens are disclosed. The antibodies are made up of variable regions for cancer antigens derived from murine immunoglobulins and constant regions from human immunoglobulins The murine variable regions retain antigen binding specificity when attached to human constant regions.
Patent DE-3782877-T2 (DE)
Inventor: VINOT BERNARD
IPC: B01J2/16
Filed: 1987-05-29
Granted: 1993-04-29
Abstract: Porous granules of biopolymers of the xanthan gum type. 
<??>The granules are obtained by granulation of biopolymer powder in a fluidised bed. 
<??>Application in all industries requiring aqueous fluids with increased viscosity. 
<IMAGE>
Patent DE-3783531-T2 (DE)
Inventor: BALANZAT EMMANUEL
IPC: C08J7/18
Filed: 1987-07-30
Granted: 1993-06-24
Abstract: The process comprises the following stages: a) immersion of the polymer in a solution of monomer for a number of hours or bringing the polymer into contact in a cell with the monomer which may be in liquid or gaseous form, b) irradiation of the whole using a beam of energetic ions of at least 1 MeV/u.m.a. at a fluence of between 10<8> and 10<1><4> ions/cm<2> at a temperature which is kept constant during the irradiation period,  c) separation of the unreacted monomer using a solvent. The products obtained are membranes which can be applied in permeation, filtration and osmosis.
Patent DE-3852816-T2 (DE)
Inventor: STOKBROEKX RAYMOND A
IPC: C07D237/24
Filed: 1988-11-17
Granted: 1995-06-08
Abstract: Novel pyridazinamine derivatives of formula <CHEM>  wherein R<1> is hydrogen, C1-6alkyl, halo, hydroxy, mercapto, trifluoromethyl, amino, mono or di(C1-6alkyl)amino, cyano, C1-6alkyloxy, aryloxy, arylC1-6alkyloxy, C1-6alkylthio, arylthio, C1-6alkylsulfinyl, C1-6alkylsulfonyl, arylsulfinyl, aryllsulfonyl, C1-6alkyloxycarbonyl, C1-6alkylcarbonyl or aryl; R<2> and R<3> each independently are hydrogen or C1-6alkyl, or R<2> and R<3> combined may form a bivalent radical of formula -CH=CH-CH=CH-  G is a bivalent radical of formula <CHEM> X is O, S, NR<8> or a direct bond; said R<8> being hydrogen or C-6alkyl; the pharmaceutically acceptable acid addition salts and possible stereochemically isomeric forms thereof, which compounds are anti-virals; pharmaceutical compositions containing such compounds as an active ingredient and methods of preparing said compounds and pharmaceutical compositions.
Patent DE-3852867-T2 (DE)
Inventor: TAKAYAMA JUN SONY CORPORATION
IPC: G11B20/12
Filed: 1988-11-21
Granted: 1995-06-22
Abstract: In this invention, a structure in which a data stream encoded into the M<2> code is cut at the boundary of its arbitrary bit cells and a unique sync pattern is inserted between the bit cells is adopted. As a result, the erroneous detection of data of the data stream modulated with the M<2> code as a sync pattern can be prevented to avoid the synchronization shift, the occurrence of the synchronization error. Further, the correct and stable synchronization can be established so as to enable reproduction of an original digital data with high fidelity. Also, by eliminating the sync pattern and connecting its data blocks before and after as they are, a data stream satisfying the rule of the code and inserting the pattern into a data stream modulated with the M<2> code.
Patent DE-3873338-T2 (DE)
Inventor: HILTUNEN OSSI
IPC: B23K9/26
Filed: 1988-02-23
Granted: 1992-12-24
Abstract: PCT No. PCT/FI88/00028 Sec. 371 Date Aug. 23, 1989 Sec. 102(e) Date Aug. 23, 1989 PCT Filed Feb. 23, 1988 PCT Pub. No. WO88/06072 PCT Pub. Date Aug. 25, 1988.The invention relates to a current nozzle for a MIG- and MAG-welding burner, comprising a nozzle body (8) having an orifice (9) for the passage of a welding wire (5). The current nozzle is provided with means for automatically turning welding wire (5) and nozzle orifice (9) eccentrically relative to each other as a function of the wearing of nozzle orifice (9). The means for turning welding wire (5) and nozzle orifice (9) relative to each other consist of a coil spring (10) surrounding nozzle body (8), one end of said spring being fastened to nozzle body (8). The other end of said coil spring is provided with a guide opening (11) for allowing said welding wire (5) to travel in axial direction through said guide opening (11).
Patent DE-3878319-T2 (DE)
Inventor: DECKER ARNOLD F
IPC: F15B13/16
Filed: 1988-06-21
Granted: 1993-08-26
Abstract: Fluid flow control valves are provided having a jet pump or aspirator (53) connected to a plurality of fluid passageways. Fluid flow from one of the passageways through the jet pump (53) creates a partial vacuum enabling fluid flow to be drawn through the other of the fluid passageways connected to the jet pump (53). Such valves enable hydraulic fluids of a single-acting piston-cylinder unit or the like to be readily exhausted. In a provided system of this invention, hydraulic or pneumatic pumps may be employed for cylinder exhaustion.
Patent DE-3878930-T2 (DE)
Inventor: SKJOLD PETERSEN JORGEN
IPC: E04B1/78
Filed: 1988-03-25
Granted: 1996-11-21
Abstract: PCT No. PCT/DK88/00050 Sec. 371 Date Nov. 25, 1988 Sec. 102(e) Date Nov. 25, 1988 PCT Filed Mar. 25, 1988 PCT Pub. No. WO88/07614 PCT Pub. Date Oct. 6, 1988.Exterior, water-repellant facing or covering for a roof or a wall. The material is in the form of plates or slabs with overlap or butt joints. The material may include a support web. To eliminate the risk of condensation and to reduce the transmission of heat, the material is formed of mineral wool and a bonding agent. The fibres of the mineral wool lie predominantly within planes which are perpendicular to the external surface of the material.
Patent DE-3885201-T2 (DE)
Inventor: HAHM PAUL TIMOTHY C O EASTMAN
IPC: G03C7/30
Filed: 1988-08-18
Granted: 1994-05-19
Abstract: A color photographic element comprising a support and first and second silver halide emulsion layers sensitized to first and second regions of the electromagnetic spectrum respectively and each containing a dye forming coupler, wherein the second emulsion layer is to a limited extent also sensitized to the first region of the spectrum. The element exhibits extended exposure latitude.
Patent TR-199802783-T2 (TR)
Inventor: FAHIM RAAFAT E F
IPC: A61P31/00
Filed: 1997-07-02
Abstract: A multi-component vaccine composition is described comprising acellular pertussis vaccine components, diphtheria toxoid, tetanus toxoid and inactivated poliovirus. The composition also may contain a conjugate of a capsular polysaccharide of  Haemophilus influenzae  type b and tetanus toxoid or diphteria toxoid, which may be reconstituted from a lyophilized state by the other components of the vaccine. The administration of the multiple component vaccine results in no diminution in the immunogenicity of any component as a result of interference by other components of the vaccine.
Patent DE-60001170-T2 (DE)
Inventor: PARADY BODO
IPC: G06F12/12
Filed: 2000-05-30
Granted: 2003-07-31
Abstract: A software methodology to control replacement of one or more selected pages within a cache memory in a computer system. The operating system designates one or more pages containing critical data, text or other digital information as hot pages within a physical system memory in the computer system and prevents replacement during execution of various application programs of these hot pages when cached. The operating system inhibits allocation of the conflict pages that would map to cache locations occupied by a cached hot page, thereby preserving the hot page within the cache memory. The conflict pages are placed at the bottom of a free list created in the system memory by the operating system. The operating system scans the free list using a pointer while allocating free system memory space at run-time. The system memory pages are allocated from the free list until the pointer reaches a conflict page. This allows the operating system to prevent the conflict pages from getting cached to the hot page location within the cache memory. The operating system can also allow a user to designate one or more hot pages during run-time. The user is warned when the number of hot pages reaches or exceeds a predetermined limit.
Patent DE-60001318-T2 (DE)
Inventor: BURCH ROBERT
IPC: B01J38/02
Filed: 2000-06-20
Granted: 2003-08-21
Abstract: The present invention relates to methods for the regeneration of catalytic reactors. In particular it relates to methods for regenerating a fuel-processing catalyst while it is still being used to supply hydrogen to a fuel cell. The temperature of the catalyst may be adjusted, the air, steam or fuel feed rate may be adjusted. Alternatively, additives may be added to the feed.
Patent DE-60007612-T2 (DE)
Inventor: NEVEU BERNARD
IPC: B01D53/86
Filed: 2000-02-15
Granted: 2004-11-04
Abstract: The invention concerns a method for purifying flue gases before they are released into the atmosphere of their nitrogen oxides N<SUB>2</SUB>O and NO<SUB>x </SUB>by reaction with ammonia by causing them to circulate at temperatures between 200 and 600° C. on a catalyst based on beta-zeolite loaded with iron. The invention is particularly useful for treating tail gases from factories producing nitric acid.
Patent DE-60013124-T2 (DE)
Inventor: KAELLANDER CLAS
IPC: G01N33/53
Filed: 2000-06-16
Granted: 2005-09-08
Abstract: A reverse transcriptase (RT) assay kit for analysis of RT activity in biological samples is described. The kit comprises solid phase bound prA and/or pdA template(s) obtainable by contacting a polystyrene-based solid phase with a 1-methylimidazole-containing coupling solution, and RT-type adapted assay components selected from a buffer, divalent metal ion, chelator, polyamine, RNase inhibitor, reducing agent, salt, stabilizing agent, and detergent, and deoxynucleotide triphosphate, primer, protective agent and concentrated washing buffer, and optionally lyophilized reference enzyme(s), and further optionally lyophilized alkaline phosphatase conjugated anti-BrdU monoclonal antibody, alkaline phosphatase substrate buffer and alkaline phosphatase substrate, and written instructions for use of the assay kit. Further, a method and a use of the assay kit for the qualitative and quantitative analysis of RT activity in a biological sample, optionally followed by evaluation of the status of a RT activity related disorder or disease based on the result of the analysis of the RT activity, are disclosed.
Patent DE-60014491-T2 (DE)
Inventor: LAFOND DIDIER
IPC: B60N2/75
Filed: 2000-05-23
Granted: 2005-10-20
Abstract: The adjustable car armrest system has an armrest (3) which can be pivoted into a raised position on a parallelogram lever system. The bottom (4) of the armrest forms a lid for a storage tray (35). This in turn forms a swivelling lid for a storage space (44).
Patent DE-60017403-T2 (DE)
Inventor: MOORE DONAL
IPC: B60R21/06
Filed: 2000-07-07
Granted: 2005-12-29
Abstract: A barrier net (10''') for motor vehicles of the type having a forward passenger compartment and cargo area behind the passenger compartment. The barrier net comprises a net member (18') adapted to restrain stowage within the cargo area from entering the passenger compartment. A mechanism is provided for removably attaching both the netting member top to the cargo area and the netting member bottom to the cargo area. The barrier net further comprises a mechanism for rendering the netting member taut.
Patent DE-60017801-T2 (DE)
Inventor: ROSSIGNOL P
IPC: A61K31/70
Filed: 2000-11-22
Granted: 2006-01-05
Abstract: The invention provides methods of preventing and treating pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin and related conditions in a patient by administering to the patient antiendotoxin compounds by inhalation.
Patent DE-60019176-T2 (DE)
Inventor: FERNANDES BRIAN C A
IPC: A61L27/40
Filed: 2000-01-28
Granted: 2005-09-22
Abstract: An implantable medical device comprising a drug-loaded polymer overlaid with a fabric that promotes tissue ingrowth is useful in a wide variety of tissue engineering applications. The invention includes, for example, prosthetic heart valves, annuloplasty rings, and grafts, having enhanced biocompatibility and biostability. Methods of making and using the implantable medical devices of the invention are also included. <IMAGE>   <IMAGE>
Patent DE-60021481-T2 (DE)
Inventor: KULKARNI SHEKHAR V
IPC: C07C333/10
Filed: 2000-05-29
Granted: 2006-04-20
Abstract: The present invention provides a process for making N-alk(en)oxy(or aryloxy)carbonyl isothiocyanate derivatives by reacting a haloformate with a thiocyanate, in the presence of an aqueous solvent or an organic solvent and a catalytic amount of a N,N-dialk(en)ylarylamine, to produce a N-alkoxy (or aryloxy)carbonyl isothiocyanate intermediate product, wherein the intermediate product is converted to a N-alk(en)oxy(or aryloxy)carbonyl isothiocyanate derivative in high yield and purity. The invention further provides a process for making N-alk(en)oxy (or aryloxy)carbonyl isothiocyanates by reacting a haloformate with a thiocyanate, in the presence of an aqueous solvent or an organic solvent and a catalytic amount of a N,N-dialk(en)ylarylamine.
Patent DE-60029743-T2 (DE)
Inventor: EIBACH WOLFGANG
IPC: H04L12/28
Filed: 2000-02-21
Granted: 2007-10-31
Abstract: Provided are apparatus and a method for establishing communications between a Web client computer in a vehicle and a Web server computer connected to the Internet or an intranet, initiated from a remote Web Browser. The Web Browser sends a request to the server, which invokes a process at the server causing a SMS message to be sent to a telephone connected to the client computer. This SMS message includes an identification of the server process (such as a URL) and causes the client computer to establish communications with the server. This allows the Browser to interact with the client computer via a standard Browser request without the overheads of security exposure of requiring the client to be a Web server. The invention is useful for allowing a remote Browser to interact with a computer controlling a vehicle's electronic control systems. <IMAGE>
Patent DE-60030989-T2 (DE)
Inventor: DORCHAK D
IPC: A61F2/46
Filed: 2000-08-28
Granted: 2007-05-24
Abstract: Instrumentation for spinal interbody fusion are disclosed. The instruments are particularly adapted for interbody fusion in an unreamed disc space. One instrument is a distractor assembly (500) including a first distractor (512a) and a second distractor (512b) configured to be inserted in side-by-side relation in the disc space. Fusion cages adapted for insertion into an unreamed disc space are provided to enhance load distribution between adjacent vertebral bodies and lateral stability of the spinal column. The fusion cages may be inserted after distracting the disc space with the distractor assembly. Instruments for preparing the disc space through the inserted fusion cages or for use with the distractor assembly are also provided.
Patent DE-60033552-T2 (DE)
Inventor: TAKAYA MINORU
IPC: B23K35/363
Filed: 2000-10-05
Granted: 2007-05-31
Abstract: The present invention relates to a soldering flux, a soldering paste and a soldering method that achieve a sufficient degree of bonding strength even when components are mounted at a higher density, components are further miniaturized or components are mounted with a smaller pitch. A flux 3 contains an adhesive resin and a hardening agent. This flux or a soldering paste containing the flux is applied onto a component mounting board 1, and then, an electronic component 4 is mounted and soldered onto the component mounting board 1.